1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Mccoy, M.A.
Stavridi, E.S.
Waterman, J.L.F.
Wieczorek, A.
Opella, S.J.
Halezonetis, T.D.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
UK
EMBO J.
EMJODG
0897
0261-4189
16
6230
6236
10.1093/emboj/16.20.6230
9321402
Hydrophobic side-chain size is a determinant of the three-dimensional structure of the p53 oligomerization domain.
1997
10.2210/pdb1a1u/pdb
pdb_00001a1u
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
4210.639
P53
OLIGOMERIZATION
M40K, F41I, L44Y
2
man
polymer
no
no
DGEYFTLQIRGRERFEKIREYNEALELKDAQAGKE
DGEYFTLQIRGRERFEKIREYNEALELKDAQAGKE
A,C
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
P53 TUMOR SUPPRESSOR
9606
Homo sapiens
562
Escherichia coli
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_sheet
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1998-04-08
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_sheet.number_strands
Y
BNL
1997-12-16
REL
NO VIOLATIONS
40
1
HNCA
HNCOCA
CBCACONH
HNCACB
3D 15N-EDITED TOCSY-HMQC
3D 15N-EDITED NOESY-HMQC
HCCH-TOCSY
2D NOESY 2D COSY
2D TOCSY
3D 13C-EDITED NOESY
3D 13C-EDITED
13C-FILTERED HMQC-NOESY
HNHA
HMQC-J
HNCA-J
7.0
313
K
DETAILS CAN BE FOUND IN EMBO J., 16, 6230-6236 (1997).
DG-SA
BRUNGER
refinement
X-PLOR
structure solution
X-PLOR
600
Bruker
DMX600
750
Bruker
DMX750
n
1
24
A
n
2
25
A
GLU
26
n
3
GLU
26
A
TYR
27
n
4
TYR
27
A
PHE
28
n
5
PHE
28
A
THR
29
n
6
THR
29
A
LEU
30
n
7
LEU
30
A
GLN
31
n
8
GLN
31
A
ILE
32
n
9
ILE
32
A
ARG
33
n
10
ARG
33
A
GLY
34
n
11
GLY
34
A
ARG
35
n
12
ARG
35
A
GLU
36
n
13
GLU
36
A
ARG
37
n
14
ARG
37
A
PHE
38
n
15
PHE
38
A
GLU
39
n
16
GLU
39
A
LYS
40
n
17
LYS
40
A
ILE
41
n
18
ILE
41
A
ARG
42
n
19
ARG
42
A
GLU
43
n
20
GLU
43
A
TYR
44
n
21
TYR
44
A
ASN
45
n
22
ASN
45
A
GLU
46
n
23
GLU
46
A
ALA
47
n
24
ALA
47
A
LEU
48
n
25
LEU
48
A
GLU
49
n
26
GLU
49
A
LEU
50
n
27
LEU
50
A
LYS
51
n
28
LYS
51
A
ASP
52
n
29
ASP
52
A
ALA
53
n
30
ALA
53
A
GLN
54
n
31
GLN
54
A
n
32
55
A
n
33
56
A
n
34
57
A
n
35
58
A
n
1
24
C
n
2
25
C
GLU
26
n
3
GLU
26
C
TYR
27
n
4
TYR
27
C
PHE
28
n
5
PHE
28
C
THR
29
n
6
THR
29
C
LEU
30
n
7
LEU
30
C
GLN
31
n
8
GLN
31
C
ILE
32
n
9
ILE
32
C
ARG
33
n
10
ARG
33
C
GLY
34
n
11
GLY
34
C
ARG
35
n
12
ARG
35
C
GLU
36
n
13
GLU
36
C
ARG
37
n
14
ARG
37
C
PHE
38
n
15
PHE
38
C
GLU
39
n
16
GLU
39
C
LYS
40
n
17
LYS
40
C
ILE
41
n
18
ILE
41
C
ARG
42
n
19
ARG
42
C
GLU
43
n
20
GLU
43
C
TYR
44
n
21
TYR
44
C
ASN
45
n
22
ASN
45
C
GLU
46
n
23
GLU
46
C
ALA
47
n
24
ALA
47
C
LEU
48
n
25
LEU
48
C
GLU
49
n
26
GLU
49
C
LEU
50
n
27
LEU
50
C
LYS
51
n
28
LYS
51
C
ASP
52
n
29
ASP
52
C
ALA
53
n
30
ALA
53
C
GLN
54
n
31
GLN
54
C
n
32
55
C
n
33
56
C
n
34
57
C
n
35
58
C
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ASP
24
A
ASP
1
1
Y
1
A
GLY
25
A
GLY
2
1
Y
1
A
ALA
55
A
ALA
32
1
Y
1
A
GLY
56
A
GLY
33
1
Y
1
A
LYS
57
A
LYS
34
1
Y
1
A
GLU
58
A
GLU
35
1
Y
1
C
ASP
24
B
ASP
1
1
Y
1
C
GLY
25
B
GLY
2
1
Y
1
C
ALA
55
B
ALA
32
1
Y
1
C
GLY
56
B
GLY
33
1
Y
1
C
LYS
57
B
LYS
34
1
Y
1
C
GLU
58
B
GLU
35
1
Y
1
A
C
HG1
HG1
THR
THR
29
29
1.35
1
A
TYR
27
-73.06
-75.29
1
A
ILE
32
-126.69
-70.56
1
A
ARG
33
88.84
92.44
1
A
ALA
53
-87.04
-87.30
1
C
TYR
27
-74.66
-75.64
1
C
ILE
32
-128.13
-69.67
1
C
ARG
33
88.15
94.28
1
C
ALA
53
-85.72
-86.22
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
SOLUTION STRUCTURE DETERMINATION OF A P53 MUTANT DIMERIZATION DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE
1
N
N
1
N
N
A
ARG
35
A
ARG
12
HELX_P
A
ASP
52
A
ASP
29
1
1
18
C
ARG
35
B
ARG
12
HELX_P
C
ASP
52
B
ASP
29
1
2
18
ANTI-ONCOGENE
P53, OLIGOMERIZATION DOMAIN, HUMAN, ANTI-ONCOGENE
P53_HUMAN
UNP
1
324
P04637
324
358
1A1U
24
58
P04637
A
1
1
35
324
358
1A1U
24
58
P04637
C
1
1
35
1
A
THR
29
A
THR
6
A
GLN
31
A
GLN
8
1
P 1